Akèy › Anjyodèm
Etid klinik pou Anjyodèm ap rekrite nan Etazini
6 etid pou Anjyodèm ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07266805Angioedema Biomarker Research Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 75 · Tout sèks · Mizajou Aug 24, 2026 · NCT06210698A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT07001280Allergy and Immunology Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 99 · Tout sèks · Mizajou Feb 4, 2026 · NCT05584488Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Jul 2, 2025 · NCT07046806Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2025 · NCT06818474Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.